Real-World Outcomes in COPD Patients Starting Trixeo (Budesonide/Glycopyrronium/Formoterol) in Spain.

Clinical trial NCT06321731 · COMPLETED

Trial details

NCT number: NCT06321731
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2024-07-02
Primary completion: 2024-12-16
Enrollment: 718

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.